AI-Designed Drug Shows 3-4 Years of Biological Age Reversal in Human Trial

Insilico Medicine's AI-discovered and AI-designed drug rentosertib, originally targeting idiopathic pulmonary fibrosis, showed a striking secondary result in a Phase IIa trial: 42 patients exhibited roughly 3-4 years of biological age reversal across six epigenetic clocks. The finding drew follow-up coverage from Japan Times and Bloomberg.

2026-10-05 ~ 2026-10-05 · 3 related posts

• AI-Designed Drug Rentosertib Shows 3-4 Years of Biological Age Reversal in Phase IIa Trial — Dr_Singularity · 2026-10-05
• Japan Times Covers Rentosertib: AI-Discovered Lung Drug Reverses Aging Markers — Dr_Singularity · 2026-10-05

1 near-duplicate retellings: Kyrannio